NCT06537505View on ClinicalTrials.gov

A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

April 1, 2027

Study Completion Date

August 31, 2027

Conditions

Solid Tumor

Interventions

DRUG

Adebrelimab

Q3W,IV

DRUG

Apatinib

QoD

PROCEDURE

microwave ablation

microwave ablation

All Listed Sponsors

lead

Beidahuang Industry Group General Hospital

OTHER